MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.

<h4>Background</h4>MicroRNA (miRNA) expression is broadly altered in cancer, but few studies have investigated miRNA deregulation in oral squamous cell carcinoma (OSCC). Epigenetic mechanisms are involved in the regulation of >30 miRNA genes in a range of tissues, and we aimed to inve...

Full description

Bibliographic Details
Main Authors: Erik D Wiklund, Shan Gao, Toby Hulf, Tennille Sibbritt, Shalima Nair, Daniela Elena Costea, Sune B Villadsen, Vivi Bakholdt, Jesper B Bramsen, Jens A Sørensen, Annelise Krogdahl, Susan J Clark, Jørgen Kjems
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22132151/pdf/?tool=EBI
id doaj-6a4353f64720418e930cb64f218f22e9
record_format Article
spelling doaj-6a4353f64720418e930cb64f218f22e92021-03-04T01:20:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01611e2784010.1371/journal.pone.0027840MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.Erik D WiklundShan GaoToby HulfTennille SibbrittShalima NairDaniela Elena CosteaSune B VilladsenVivi BakholdtJesper B BramsenJens A SørensenAnnelise KrogdahlSusan J ClarkJørgen Kjems<h4>Background</h4>MicroRNA (miRNA) expression is broadly altered in cancer, but few studies have investigated miRNA deregulation in oral squamous cell carcinoma (OSCC). Epigenetic mechanisms are involved in the regulation of >30 miRNA genes in a range of tissues, and we aimed to investigate this further in OSCC.<h4>Methods</h4>TaqMan® qRT-PCR arrays and individual assays were used to profile miRNA expression in a panel of 25 tumors with matched adjacent tissues from patients with OSCC, and 8 control paired oral stroma and epithelium from healthy volunteers. Associated DNA methylation changes of candidate epigenetically deregulated miRNA genes were measured in the same samples using the MassArray® mass spectrometry platform. MiRNA expression and DNA methylation changes were also investigated in FACS sorted CD44(high) oral cancer stem cells from primary tumor samples (CSCs), and in oral rinse and saliva from 15 OSCC patients and 7 healthy volunteers.<h4>Results</h4>MiRNA expression patterns were consistent in healthy oral epithelium and stroma, but broadly altered in both tumor and adjacent tissue from OSCC patients. MiR-375 is repressed and miR-127 activated in OSCC, and we confirm previous reports of miR-137 hypermethylation in oral cancer. The miR-200 s/miR-205 were epigenetically activated in tumors vs normal tissues, but repressed in the absence of DNA hypermethylation specifically in CD44(high) oral CSCs. Aberrant miR-375 and miR-200a expression and miR-200c-141 methylation could be detected in and distinguish OSCC patient oral rinse and saliva from healthy volunteers, suggesting a potential clinical application for OSCC specific miRNA signatures in oral fluids.<h4>Conclusions</h4>MiRNA expression and DNA methylation changes are a common event in OSCC, and we suggest miR-375, miR-127, miR-137, the miR-200 family and miR-205 as promising candidates for future investigations. Although overall activated in OSCC, miR-200/miR-205 suppression in oral CSCs indicate that cell specific silencing of these miRNAs may drive tumor expansion and progression.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22132151/pdf/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Erik D Wiklund
Shan Gao
Toby Hulf
Tennille Sibbritt
Shalima Nair
Daniela Elena Costea
Sune B Villadsen
Vivi Bakholdt
Jesper B Bramsen
Jens A Sørensen
Annelise Krogdahl
Susan J Clark
Jørgen Kjems
spellingShingle Erik D Wiklund
Shan Gao
Toby Hulf
Tennille Sibbritt
Shalima Nair
Daniela Elena Costea
Sune B Villadsen
Vivi Bakholdt
Jesper B Bramsen
Jens A Sørensen
Annelise Krogdahl
Susan J Clark
Jørgen Kjems
MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
PLoS ONE
author_facet Erik D Wiklund
Shan Gao
Toby Hulf
Tennille Sibbritt
Shalima Nair
Daniela Elena Costea
Sune B Villadsen
Vivi Bakholdt
Jesper B Bramsen
Jens A Sørensen
Annelise Krogdahl
Susan J Clark
Jørgen Kjems
author_sort Erik D Wiklund
title MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
title_short MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
title_full MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
title_fullStr MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
title_full_unstemmed MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
title_sort microrna alterations and associated aberrant dna methylation patterns across multiple sample types in oral squamous cell carcinoma.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-01-01
description <h4>Background</h4>MicroRNA (miRNA) expression is broadly altered in cancer, but few studies have investigated miRNA deregulation in oral squamous cell carcinoma (OSCC). Epigenetic mechanisms are involved in the regulation of >30 miRNA genes in a range of tissues, and we aimed to investigate this further in OSCC.<h4>Methods</h4>TaqMan® qRT-PCR arrays and individual assays were used to profile miRNA expression in a panel of 25 tumors with matched adjacent tissues from patients with OSCC, and 8 control paired oral stroma and epithelium from healthy volunteers. Associated DNA methylation changes of candidate epigenetically deregulated miRNA genes were measured in the same samples using the MassArray® mass spectrometry platform. MiRNA expression and DNA methylation changes were also investigated in FACS sorted CD44(high) oral cancer stem cells from primary tumor samples (CSCs), and in oral rinse and saliva from 15 OSCC patients and 7 healthy volunteers.<h4>Results</h4>MiRNA expression patterns were consistent in healthy oral epithelium and stroma, but broadly altered in both tumor and adjacent tissue from OSCC patients. MiR-375 is repressed and miR-127 activated in OSCC, and we confirm previous reports of miR-137 hypermethylation in oral cancer. The miR-200 s/miR-205 were epigenetically activated in tumors vs normal tissues, but repressed in the absence of DNA hypermethylation specifically in CD44(high) oral CSCs. Aberrant miR-375 and miR-200a expression and miR-200c-141 methylation could be detected in and distinguish OSCC patient oral rinse and saliva from healthy volunteers, suggesting a potential clinical application for OSCC specific miRNA signatures in oral fluids.<h4>Conclusions</h4>MiRNA expression and DNA methylation changes are a common event in OSCC, and we suggest miR-375, miR-127, miR-137, the miR-200 family and miR-205 as promising candidates for future investigations. Although overall activated in OSCC, miR-200/miR-205 suppression in oral CSCs indicate that cell specific silencing of these miRNAs may drive tumor expansion and progression.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22132151/pdf/?tool=EBI
work_keys_str_mv AT erikdwiklund micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT shangao micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT tobyhulf micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT tennillesibbritt micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT shalimanair micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT danielaelenacostea micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT sunebvilladsen micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT vivibakholdt micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT jesperbbramsen micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT jensasørensen micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT annelisekrogdahl micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT susanjclark micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
AT jørgenkjems micrornaalterationsandassociatedaberrantdnamethylationpatternsacrossmultiplesampletypesinoralsquamouscellcarcinoma
_version_ 1714809602408710144